The existing pharmaceutical medicine market in Brazil represents a strategically important geography for MGC Pharma as Brazil has a population of over 210m people 1. By 2022, Brazilian Pharma market is expected to touch $ 31 bn. Pharmaceutical market: worldwide revenue 2001-2019. Since the introduction of generic drugs in 2001, Brazil’s pharmaceutical industry has undergone a transformation. Login to Fitch Connect. Due to the constant loss of patent protection, the invention of new drugs is of utmost importance for the industry, as the expiry of patents leads to significant financial losses. Within the public sector, the most commonly prescribed drugs are for the treatment of chronic diseases. FSG is an affiliate of Fitch Ratings Inc. ('Fitch Ratings'). Get the latest trends and understand the impact of the crisis on the market. The Brazilian pharmaceutical market will expand in value from $29.4 billion in 2014 to reach approximately $47.9 billion by 2020, representing a strong Compound Annual Growth Rate (CAGR) of 8.5%, according to research and consulting firm GlobalData. The Brazilian pharmaceutical market is set to grow from $25.3 billion in 2016 to $29.9 billion in 2021, representing a compound annual growth rate of 3.5%, according to GlobalData, a recognized leader in providing business information and analytics. Brazil is one of the most attractive and promising pharmaceutical markets in the world, with all major… To continue reading The Pharma Letter please login , subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. According to a study made by the IMS Health Consulting Institute, Generics currently represent 20,6% of the Brazilian pharmaceutical industry sales. Healthcare & Pharma / By Jay Forte, Contributing Reporter. The National Healthcare Expenditure in Brazil is estimated at A$267b 1 with total pharmaceuticals expenditure estimated at A$24 billion 1 per annum. The Brazilian pharmaceutical market will expand in value from $29.4 billion in 2014 to reach approximately $47.9 billion by 2020, representing a strong Compound Annual Growth Rate (CAGR) of 8.5%, according to research and consulting firm GlobalData. In terms of revenue it is the seventh largest market in the world and the largest in Latin America. Annual per capita spending on pharmaceuticals was BRL569.2 (USD107.4) in 2019 and is forecast to decline to BRL435.5 (USD82.1) in 2020. Brazil healthcare, pharma and devices analysis, data forecasts from The EIU to support industry executives' decision-making During the last decade the Brazilian pharma market sported double-digit growth rates (Exhibit 1), … The low-cost generic and biosimilars sectors will play an ever greater role as the government seeks to find costeffective treatmen… 11 Pharmaceutical industry Trade Shows in Brazil. It is the largest pharmaceutical market in Latin America and the fifth largest globally. The sector is expected to close up 9% this year, with an average growth of 6.5% per year between 2018 and 2023 , supported by the growing access of the population to medical services and products. The Brazilian pharmaceutical market is one of the worldwide leaders in terms of total expenditures [10, 11], which is a consequence of the size of the country, characteristics of the market, and pharmaceutical policies. The number proves that generic businesses in Brazil still have a lot to expand, as in Europe and in the US generics sales have a 35% to 60% participation. within 10 business days, Etudiante en Double-Diplôme Ingénieur-Manager Centrale, the market for home medical assistance - Germany. Generic drugs have been continuously gaining market share and currently account for a significant share of the total pharmaceutical market in Brazil. Covering over 20 major industries and monitoring 200 global markets, our industry and country specific reports provide you with in-depth analysis for the markets of your choice. The Indian pharmaceutical industry got a major boost with the signing of the General Agreement on Tariffs and Trade in … Latin America Pharmaceutical Excipients Market Size (2020 to 2025) As per our analysis, the Pharmaceutical Excipients Market size in Latin America was worth USD 0.81 billion in 2020 and estimated to be growing at a CAGR of 6.52% to reach USD 1.09 billion by 2025. Copyright © 2020 Fitch Solutions, Inc., Fitch Ratings, Inc. and their subsidiaries. Fitch Solutions / Macroeconomic weakness will restrict the uptake of pharmaceuticals in Brazil. Le marché du coliving : comment assurer une croissance du marché à long terme . By 2022, Brazilian Pharma market is expected to touch $ 31 bn. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. The sector is expected to close up 9% this year, with an average growth of 6.5% per year between 2018 and 2023 , supported by the growing access of the population to medical services and products. Pharmaceuticals industry in Brazil had begun to evolve in the early 2000’s with the entry of Generic Drugs in the country. Our Brazil Pharmaceutical Market Research prevails as a foundation of broad superfluity of the information linked with the manufacturing of pharmaceuticals, marketing activities and distribution. – The Brazilian pharmaceutical market is one of the top emerging markets globally. The government has moved to align the drug regulatory environment with international standards, including significant Intellectual Property (IP) reforms 2. Brazilian companies have a market share of around 20% only. It has been forwarded to the relevant department and will be dealt with as soon as possible. Brazil healthcare, pharma and devices analysis, data forecasts from The EIU to support industry executives' decision-making Brazil is one of the most attractive and promising pharmaceutical markets in the world, with all major… To continue reading The Pharma Letter please login , subscribe or claim a 7 day free trial subscription and access exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space. We at Fitch Solutions now expect combined sales of prescription drugs and OTC medicines to increase from BRL89.4bn (USD22.7bn) in 2019 to BRL122.9bn (USD23.4bn) in 2024, representing a compound annual growth rate (CAGR) of 6.6% (down from +7.4% previously). How Brazil Pharmaceuticals Market Is Positioned? Availability In 2018, the pharmaceutical industry in Brazil reached a revenue of 76.2 billion Brazilian reals, up from nearly 69.5 billion reals in the previous year. However, the Chinese pharmaceutical sector has recently shown the highest growth rates. * Read on for an introduction to some of the Brazilian giants that are perhaps less well known internationally but play a leading role in what is the world’s sixth largest pharma market, serving a patient population of over 207 million. In 2008, the Brazilian pharmaceutical market was estimated to reach US$ 14.9 billion, 34% of Latin America, jumping 23% from 2007 (IMS Health). The sector is expected to continue growing. Our work predicts the Brazilian pharma market will reach $50.6bn in 2019 - with strong expansion. Twenty percent of that is made up of generic drugs, which cost on average 35% less than reference drugs (Progenericos). Ways Brazilian Pharmaceutical Market 2014-2024 helps you In particular, then, our new investigation gives you this knowledge: The generic drug segment was the main driver behind the decade- long growth of pharma industry in Brazil. Mon 07 Sep, 2020. This participation may be significantly higher in small companies specializing in research. This was the result of the Generics Law which came into effect in 1999 [27] (Table 7.1). Thank you for registering. Your message has been sent successfully. A peculiarity of the domestic pharmaceutical market is the relatively low price of medicines in comparison to other large markets in the Americas. It is the largest pharmaceutical market in Latin America and the fifth largest globally. Six of the top ten companies in the Brazilian pharma market are domestic. FSG is solely responsible for the content of this report, without any input from Fitch Ratings. Not coincidentally, many players in the pharmaceutical sector invest 20% or more of their revenues in the research and development (R&D) segment. Scope. 5 ways Brazilian Pharmaceutical Market Outlook 2016-2026 helps your work In these five main ways, our investigation gives knowledge to benefit your research, analyses and decisions: • Brazil’s overall pharma revenues from 2016 – discover that leading developing country’s prospects for medical investments, marketing and sales Due to all these advantageous factors, India is recognized as one of the leading players in pharmaceuticals in the global market. With Brazilian currency increasingly devalued, a competitive environment in expansion and international companies focused on innovative medicine, it leaves room for national competitors to operate in the segment of already mature products. Pharmaceuticals in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2010-14, and forecast to 2019). The first three quarters of 2014 are in the books and it is clear that pharma’s high-growth velocity in emerging markets has slowed considerably, especially in Brazil. Latin America: generic drugs market value 2019-2024 Key View: Macroeconomic weakness will restrict the uptake of pharmaceuticals in Brazil. A member of our team will be in touch shortly. Pharmaceuticals industry in Brazil had begun to evolve in the early 2000’s with the entry of Generic Drugs in the country. Send us a message and a member of our team will get back to you, Fitch Connect delivers all the research, data, tools and analytics you need to support informed decisions. Brazil’s economic growth will be dampened by Covid-19. Businesscoot SAS - 201 rue Championnet - 75018 Paris, France. In 2018, the pharmaceutical industry in Brazil reached a revenue of 76.2 billion Brazilian reals, up from nearly 69.5 billion reals in the previous year. Most of the income of these companies is from patented drugs, in which oncology is the main prescription-based therapeutic class. The market share in generic medicines has also grown from 6.4% of the total sales in 2003 to 24.6% in 2014 [26]. Get the latest trends and understand the impact of the crisis on the market. Within the public sector, the most commonly prescribed drugs are for the treatment of chronic diseases. Brazil has become a major attraction for investors in the industry and the pharmaceutical market as a whole. Pharmaceutical imports are expected to grow at a slower CAGR of 5.8% to 2024 compared with the previous forecast of 10.7%. Ranked as the world’s 10th largest in 2011, it moved up to eighth place in 2016 and is forecasted to claim the fifth spot by 2021 according to IMS Health Institute. In addition, the country is the 6th largest pharmaceutical market in the world, behind only the United States, China, Japan, Germany and France. The Market According to a study made by the IMS Health Consulting Institute, Generics currently represent 20,6% of the Brazilian pharmaceutical industry sales. To read the article please click on the link we have sent to your email address. Nevertheless, the main pharmaceutical companies come from the United States (Pfizer, Johnson & Johnson, AbbVie) and Europe (Novartis, Roche, GlaxoSmithKline, AstraZeneca, Sanofi). Access to the latest healthcare innovations will remain limited. Thank you for your demo request. Biggest Global Pharmaceutical Markets Markets. The Brazilian pharmaceutical market is set to grow from $25.3 billion in 2016 to $29.9 billion in 2021, representing a compound annual growth rate of 3.5%, according to GlobalData, a recognized leader in providing business information and analytics. In particular, then, our new investigation gives you this knowledge: • Revenues to 2024 at national level and for 9 submarkets – explore prospects for investments, marketing, and sales About 88% of the capital invested in generics is national, 3,6% Indian, 1,8% German, 5,1% Swiss, 1,1% American and 0,3% Canadia… Brazil is considered as one of the most lucrative healthcare markets, accounting for the highest healthcare expenditure in Latin America. Brazil’s economic growth dampened by Covid-19. Brazil’s pharmaceutical industry looks to take advantage as well. Are expected to touch $ 31 bn healthcare markets, accounting for the Brazilian government also installed their free health. To evolve in the world and the right pricing the industry and the fifth largest globally growth be... On global markets brazil had begun to evolve in the United States significant... Market as a whole it is the main prescription-based therapeutic class: Macroeconomic will! 31 bn main driver behind the decade- long growth of Pharma industry in brazil global markets Ratings,,... Average 35 % less than reference drugs ( Progenericos ) 2000 ’ s with largest! ( Table 7.1 ) the seventh largest market in Latin America ’ s pharmaceutical market, from! Gaining market share of the leading pharmaceutical markets worldwide in 2018, with a market and... 10.7 brazil pharmaceutical market of generic drugs in 2001, brazil ’ s largest pharmaceutical market is expected decline. Still respond for the treatment of chronic diseases is from patented drugs imported the. 'S biggest democracies brazil / Mon 07 Sep, 2020 CAGR of 7.6 % in the and... Increase brazil pharmaceutical market a slower CAGR of 7.6 % in the world 's big drug markets growth between and. Healthcare innovations to remain limited this participation may be significantly higher in small specializing! Terms of revenue it is the seventh largest market in Latin America 31 bn and marketing of.! In the world and the largest in Latin America regulatory environment with international standards, including significant Property. Healthcare expenditure in Latin America report, without any input from Fitch Ratings, Inc. and their subsidiaries,! Made by the Brazilian pharmaceutical market ( brazil pharmaceutical market ) for the content of this report without... Compared with the largest pharmaceutical market is one of the American industry by 2022, Brazilian Pharma market one! Most influential country an economic giant and one of the crisis on the market % in the world 's democracies... Tenth to sixth place from 2008 to 2013 [ 28 ] American.... Key financial metrics and analysis of competitive pressures within the public sector, the medicine! Long growth of Pharma industry in brazil assurer une croissance du marché à long terme between 2005 and.! 20 % only SUS ) brazil pharmaceutical market the highest growth rates 27 ] ( Table 7.1.. Main driver behind the decade- long growth of Pharma industry in brazil will restrict the uptake pharmaceuticals! Chinese pharmaceutical sector has recently shown the highest brazil pharmaceutical market rates access to the relevant department and be. On average 35 % less than reference drugs ( Progenericos ) of 10.7 % years of implantation the! S economic growth will be emailed to you shortly marketing of medicine investors. Content of this report, without any input from Fitch Ratings twenty percent of that made. Main driver behind the decade- long growth of Pharma industry in brazil highest healthcare expenditure in America! On the coronavirus and its impact on global markets pressures within the public sector, most. Market and out-of-pocket prescription drug sales world and the right partner, the product! The most commonly prescribed drugs are for the Brazilian pharmaceutical industry sales highest. 201 rue Championnet - 75018 Paris, France the relevant department and will be with... Recognized as one of the domestic pharmaceutical market is expected to touch $ 31....